Skip to main content

Screening for Oral Cancer

  • Chapter
  • First Online:
Textbook of Oral Cancer

Part of the book series: Textbooks in Contemporary Dentistry ((TECD))

Abstract

Oral cancer is a serious health problem and appears to be amenable to screening. The oral cavity is easy to examine, and studies have shown that healthcare workers can detect oral potentially malignant lesions with a sensitivity and specificity similar to that found to be acceptable in other screening programs. However, there remain considerable barriers to the implementation of screening programs. The criteria for a positive test may not detect the lesions that are most likely to be malignant or that will progress to malignancy, and there is a lack of evidence to show that a screening program will reduce mortality. Studies have suggested that opportunistic screening of high-risk groups may be effective and cost-effective, but further research is needed to refine the criteria for a positive screen and to determine the best methods for identifying and targeting high-risk groups.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization. National cancer control programmes: policies and managerial guidelines. 2nd ed. WHO; 2002. www.who.int/cancer/media/en/408.pdf.

  2. Petersen PE. Oral cancer prevention and control – the approach of the World Health Organization. Oral Oncol. 2009;45:454–60.

    Article  PubMed  Google Scholar 

  3. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO; 1968.

    Google Scholar 

  4. UK National Screening Committee. Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. London, UK: National Screening Committee, 2003. Updated 2015: https://www.gov.uk/government/publications/evidence-review-criteria-national-screening-programmes.

  5. Oral cancer Screening. National Cancer Institute: U.S. National Institutes of Health. http://www.cancer.gov/cancertopics/pdq/screening/oral/healthprofessional.

  6. U.S. Preventive Services Task Force: Screening for Oral Cancer: Recommendation Statement. Rockville: U.S. Preventive Services Task Force, 2004. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/oral-cancer-screening1.

  7. Speight PM, Epstein J, Kujan O, Lingen MW, Nagao T, Ranganathan K, Vargas P. Screening for oral cancer – a perspective from the Global Oral Cancer Forum. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;123:680–7.

    Article  PubMed  Google Scholar 

  8. Parkin DM, Moss SM. Lung cancer screening: improved survival but no reduction in deaths–the role of “overdiagnosis”. Cancer. 2000;89(11 Suppl):2369–76.

    Article  PubMed  Google Scholar 

  9. Chamberlain J, Moss S, editors. Evaluation of cancer screening. London: Springer; 1996.

    Google Scholar 

  10. Vermeer NC, Snijders HS, Holman FA, Liefers GJ, Bastiaannet E, van de Velde CJ, Peeters KC. Colorectal cancer screening: systematic review of screen-related morbidity and mortality. Cancer Treat Rev. 2017;54:87–98.

    Article  PubMed  Google Scholar 

  11. de Koning HJ, Gulati R, Moss SM, Hugosson J, Pinsky PF, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, de Carvalho TM, Feuer EJ, Tsodikov A, Mariotto AB, Heijnsdijk EAM, Etzioni R. The efficacy of prostate-specific antigen screening: impact of key components in the ERSPC and PLCO trials. Cancer. 2018;124:1197–206.

    Article  PubMed  Google Scholar 

  12. Chamberlain J. Evaluation of screening for cancer. Community Dent Health. 1993;10(Suppl 1):5–11.

    PubMed  Google Scholar 

  13. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309–16.

    Article  PubMed  Google Scholar 

  14. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359–86.

    Article  PubMed  Google Scholar 

  15. Seoane J, Alvarez-Novoa P, Gomez I, et al. Early oral cancer diagnosis: The Aarhus statement perspective. A systematic review and meta-analysis. Head Neck. 2016;38(Suppl 1):E2182–9.

    Article  PubMed  Google Scholar 

  16. Rogers SN, Brown JS, Woolgar JA, et al. Survival following primary surgery for oral cancer. Oral Oncol. 2009;45:201–11.

    Article  PubMed  Google Scholar 

  17. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575–80.

    Article  PubMed  Google Scholar 

  18. Chang IH, Jiang RS, Wong YK, Wu SH, Chen FJ, Liu SA. Visual screening of oral cavity cancer in a male population: experience from a medical center. J Chin Med Assoc. 2011;74:561–6.

    Article  PubMed  Google Scholar 

  19. Downer MC, Evans AW, Hughes Hallett CM, Jullien JA, Speight PM, Zakrzewska JM. Evaluation of screening for oral cancer and precancer in a company headquarters. Community Dent Oral Epidemiol. 1995;23:84–8.

    Article  PubMed  Google Scholar 

  20. Ikeda N, Downer MC, Ishii T, Fukano H, Nagao T, Inoue K. Annual screening for oral cancer and precancer by invitation to 60 year-old residents of a city in Japan. Community Dent Health. 1995;12:133–7.

    PubMed  Google Scholar 

  21. Jullien JA, Downer MC, Zakrzewska JM, Speight PM. Evaluation of a screening test for the early detection of oral cancer and precancer. Community Dent Health. 1995;12:3–7.

    PubMed  Google Scholar 

  22. Mathew B, Sankaranarayanan R, Sunilkumar KB, Kuruvila B, Pisani P, Nair MK. Reproducibility and validity of oral visual inspection by trained health workers in the detection of oral precancer and cancer. Brit J Cancer. 1997;76:390–4.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Mehta FS, Gupta PC, Bhonsle RB, et al. Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev. 1986;9:219–25.

    PubMed  Google Scholar 

  24. Warnakulasuriya S, Pindborg JJ. Reliability of oral precancer screening by primary health care workers in Sri Lanka. Community Dent Health. 1990;7:73–9.

    PubMed  Google Scholar 

  25. Monteiro LS, Salazar F, Pacheco JJ, Martins M, Warnakulasuriya S. Outcomes of invitational and opportunistic oral cancer screening initiatives in Oporto, Portugal. J Oral Pathol Med. 2015 Feb;44:145–52.

    Article  PubMed  Google Scholar 

  26. Nagao T, Ikeda N, Fukano H, Miyazaki H, Yano M, Warnakulasuriya S. Outcome following a population screening programme for oral cancer and precancer in Japan. Oral Oncol. 2000 Jul;36:340–6.

    Article  PubMed  Google Scholar 

  27. Walsh T, Liu JL, Brocklehurst P, Glenny AM, Lingen M, Kerr AR, et al. Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev. 2013;11:CD010173.

    Google Scholar 

  28. Downer MC, Moles DR, Palmer S, Speight PM. A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol. 2004;40:264–73.

    Article  PubMed  Google Scholar 

  29. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol. 2003;39:770–80.

    Article  PubMed  Google Scholar 

  30. Napier SS, Speight PM. Natural history of potentially malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1–10.

    Article  PubMed  Google Scholar 

  31. Warnakulasuriya S, Ariyawardana A. Malignant transformation of oral leukoplakia: a systematic review of observational studies. J Oral Pathol Med. 2016;45:155–66.

    Article  PubMed  Google Scholar 

  32. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;. pii: S2212-4403(17)31248-8.

    Google Scholar 

  33. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008;3:127–33.

    Article  Google Scholar 

  34. Warnakulasuriya S. Lack of molecular markers to predict malignant potential of oral precancer. J Pathol. 2000;190:407–9.

    Article  PubMed  Google Scholar 

  35. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44:10–22.

    Article  PubMed  Google Scholar 

  36. Macey R, Walsh T, Brocklehurst P, Kerr AR, Liu JL, Lingen MW, et al. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2015;5:CD010276.

    Google Scholar 

  37. Lingen MW, Tampi MP, Urquhart O, Abt E, Agrawal N, Chaturvedi AK, Cohen E, D'Souza G, Gurenlian J, Kalmar JR, Kerr AR, Lambert PM, Patton LL, Sollecito TP, Truelove E, Banfield L, Carrasco-Labra A. Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association. J Am Dent Assoc. 2017;148:797–813.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Lingen MW, Abt E, Agrawal N, Chaturvedi AK, Cohen E, D'Souza G, Gurenlian J, Kalmar JR, Kerr AR, Lambert PM, Patton LL, Sollecito TP, Truelove E, Tampi MP, Urquhart O, Banfield L, Carrasco-Labra A. Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American Dental Association. J Am Dent Assoc. 2017;148:712–27.

    Article  PubMed  Google Scholar 

  39. Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010;141:509–20.

    Article  PubMed  Google Scholar 

  40. González RS. Cancer screening: global debates and Cuban experience. MEDICC Rev. 2014;16:73–7.

    PubMed  Google Scholar 

  41. Santana JC, Delgado L, Miranda J, Sánchez M. Oral Cancer Case Finding Program (OCCFP). Oral Oncol. 1997;33:10–2.

    Article  PubMed  Google Scholar 

  42. Frenández Garrote L, Sankaranarayanan R, Lence Anta JJ, Rodriguez Salvá A, Maxwell Parkin D. An evaluation of the oral cancer control program in Cuba. Epidemiology. 1995;6:428–31.

    Article  PubMed  Google Scholar 

  43. Yen AM, Chen SC, Chen TH. Dose-response relationships of oral habits associated with the risk of oral pre-malignant lesions among men who chew betel quid. Oral Oncol. 2007;43:634–8.

    Article  PubMed  Google Scholar 

  44. Chen TH, Chiu YH, Luh DL, et al. Community-based multiple screening model: design, implementation, and analysis of 42,387 participants. Cancer. 2004;100:1734–43.

    Article  PubMed  Google Scholar 

  45. Taiwan Breast cancer, Oral cancer and Colorectal cancer Screening Programs. Taiwan Ministry of Health and Welfare. https://www.hpa.gov.tw/EngPages/Detail.aspx?nodeid=1051&pid=5957. Accessed May 2018.

  46. Brocklehurst P, Kujan O, O’Malley LA, Ogden G, Shepherd S, Glenny AM. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev. 2013;11:CD004150.

    Google Scholar 

  47. Sankaranarayanan R, Mathew B, Jacob BJ, Thomas G, Somanathan T, Pisani P, Pandey M, Ramadas K, Najeeb K, Abraham E. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group. Cancer. 2000;88:664–73.

    Article  PubMed  Google Scholar 

  48. Ramadas K, Sankaranarayanan R, Jacob BJ, Thomas G, Somanathan T, Mahe C, Pandey M, Abraham E, Najeeb S, Mathew B, Parkin DM, Nair MK. Interim results from a cluster randomized controlled oral cancer screening trial in Kerala, India. Oral Oncol. 2003;39:580–8.

    Article  PubMed  Google Scholar 

  49. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, Rajan B, Trivandrum Oral Cancer Screening Study Group. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005;365:1927–33.

    Article  PubMed  Google Scholar 

  50. Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Thomas G, Anju G, Mathew B. Long term effect of visual screening on oral cancer incidence and mortality in a randomized trial in Kerala, India. Oral Oncol. 2013;49:314–21.

    Article  PubMed  Google Scholar 

  51. Subramanian S, Sankaranarayanan R, Bapat B, Somanathan T, Thomas G, Mathew B, Vinoda J, Ramadas K. Cost-effectiveness of oral cancer screening: results from a cluster randomized controlled trial in India. Bull World Health Organ. 2009;87:200–6.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Chuang SL, Su WW, Chen SL, Yen AM, Wang CP, Fann JC, Chiu SY, Lee YC, Chiu HM, Chang DC, Jou YY, Wu CY, Chen HH, Chen MK, Chiou ST. Population-based screening program for reducing oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers. Cancer. 2017;123:1597–609.

    Article  PubMed  Google Scholar 

  53. Downer MC, Jullien JA, Speight PM. An interim determination of health gain from oral cancer and precancer screening: 1. Obtaining health state utilities. Community Dent Health. 1997;14:139–42.

    PubMed  Google Scholar 

  54. Downer MC, Jullien JA, Speight PM. An interim determination of health gain from oral cancer and precancer screening: 2. Developing a model of population screening. Community Dent Health. 1997;14:227–32.

    PubMed  Google Scholar 

  55. Woods B, Revill P, Sculpher M, Claxton K. Country-level cost-effectiveness thresholds: initial estimates and the need for further research. Value Health. 2016;19:929–35.

    Article  PubMed  PubMed Central  Google Scholar 

  56. National Institute for Health and Care Excellence (NICE). Carrying NICE over the threshold. https://www.nice.org.uk/news/blog/carrying-nice-over-the-threshold. Accessed May 2018.

  57. Neumann PJ, Cohen JT, Weinstein MC. Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014;371:796–7.

    Article  PubMed  Google Scholar 

  58. Speight PM, Palmer S, Moles DR, Downer MC, Smith DH, Henriksson M, Augustovski F. The cost-effectiveness of screening for oral cancer in primary care. Health Technol Assess. 2006;10:1–144.

    Article  PubMed  Google Scholar 

  59. Netuveli G, Sheiham A, Watt RG. Does the ‘inverse screening law’ apply to oral cancer screening and regular dental check-ups? J Med Screen. 2006;13:47–50.

    Article  PubMed  Google Scholar 

  60. Yusof ZY, Netuveli G, Ramli AS, Sheiham A. Is opportunistic oral cancer screening by dentists feasible? An analysis of the patterns of dental attendance of a nationally representative sample over 10 years. Oral Health Prev Dent. 2006;4:165–71.

    PubMed  Google Scholar 

  61. Nagao T, Warnakulasuriya S, Ikeda N, Fukano H, Fujiwara K, Miyazaki H. Oral cancer screening as an integral part of general health screening in Tokoname City, Japan. J Med Screen. 2000;7:203–8.

    Article  PubMed  Google Scholar 

  62. Nagao T, Warnakulasuriya S. Annual screening for oral cancer detection. Cancer Detect Prev. 2003;27:333–7.

    Article  PubMed  Google Scholar 

  63. Warnakulasuriya KA, Harris CK, Scarrott DM, Watt R, Gelbier S, Peters TJ, Johnson NW. An alarming lack of public awareness towards oral cancer. Br Dent J. 1999;187:319–22.

    Article  PubMed  Google Scholar 

  64. van der Waal I. Are we able to reduce the mortality and morbidity of oral cancer; some considerations. Med Oral Patol Oral Cir Bucal. 2013;18:e33–7.

    Article  PubMed  Google Scholar 

  65. Langevin SM, Michaud DS, Eliot M, Peters ES, McClean MD, Kelsey KT. Regular dental visits are associated with earlier stage at diagnosis for oral and pharyngeal cancer. Cancer Causes Control. 2012;23:1821–9.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42:461–74.

    Article  PubMed  Google Scholar 

  67. Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med. 2007;36:262–6.

    Article  PubMed  Google Scholar 

  68. Lodi G, Franchini R, Warnakulasuriya S, et al. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev. 2016;7:CD001829.

    PubMed  Google Scholar 

  69. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and follow-up of oral dysplasia – a systematic review and meta-analysis. Head Neck. 2009;31:1600–9.

    Article  Google Scholar 

  70. Holmstrup P. Can we prevent malignancy by treating premalignant lesions? Oral Oncol. 2009;45:549–50.

    Article  PubMed  Google Scholar 

  71. Holmstrup P, Dabelsteen E. Oral leukoplakia-to treat or not to treat. Oral Dis. 2016;22:494–7.

    Article  PubMed  Google Scholar 

  72. McGurk M, Scott SE. The reality of identifying early oral cancer in the general dental practice. Br Dent J. 2010;208:347–51.

    Article  PubMed  Google Scholar 

  73. Lim K, Moles DR, Downer MC, Speight PM. Opportunistic screening for oral cancer and precancer in general dental practice: results of a demonstration study. Br Dent J. 2003;194:497–502.

    Article  PubMed  Google Scholar 

  74. Speight PM, Elliott AE, Jullien JA, Downer MC, Zakzrewska JM. The use of artificial intelligence to identify people at risk of oral cancer and precancer. Br Dent J. 1995;179:382–7.

    Article  PubMed  Google Scholar 

  75. Speight PM, Hammond P. The use of machine learning in screening for oral cancer. In: Naguib RNG, Sherbet GV, editors. Artificial neural networks in cancer diagnosis, prognosis, and patient management. Boca Raton: CRC Press; 2001.

    Google Scholar 

  76. Bhatt S, Evans J. Mobile healthcare for cancer care and control in low- and middle-income countries. In: Finkel ML, editor. Cancer screening in the developing world. New England: Dartmouth College Press; 2018.

    Google Scholar 

  77. Birur PN, Sunny SP, Jena S, Kandasarma U, Raghavan S, Ramaswamy B, Shanmugam SP, Patrick S, Kuriakose R, Mallaiah J, Suresh A, Chigurupati R, Desai R, Kuriakose MA. Mobile health application for remote oral cancer surveillance. J Am Dent Assoc. 2015;146:886–94.

    Article  PubMed  Google Scholar 

  78. Haron N, Zain RB, Nabillah WM, Saleh A, Kallarakkal TG, Ramanathan A, Sinon SH, Razak IA, Cheong SC. Mobile phone imaging in low resource settings for early detection of oral cancer and concordance with clinical oral examination. Telemed J E Health. 2017;23:192–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul M. Speight .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Speight, P.M. (2020). Screening for Oral Cancer. In: Warnakulasuriya, S., Greenspan, J. (eds) Textbook of Oral Cancer. Textbooks in Contemporary Dentistry. Springer, Cham. https://doi.org/10.1007/978-3-030-32316-5_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-32316-5_16

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-32315-8

  • Online ISBN: 978-3-030-32316-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics